Transcranial Doppler During Liver Transplantation
Primary Purpose
Liver Transplantation, Ultrasonography, Doppler, Transcranial, Complication, Postoperative
Status
Recruiting
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Transcranial Doppler
Sponsored by
About this trial
This is an interventional screening trial for Liver Transplantation
Eligibility Criteria
Inclusion Criteria:
- all patients scheduled for living donor liver transplantation for whatever the indication at Gastrointestinal surgery center (GISC)
Exclusion Criteria:
- Patients with coexisting neuropsychiatric or cerebrovascular disorders or those who have a history of head trauma or brain surgery
Sites / Locations
- Mansoura University, Gastrointestinal Surgery Center, Liver Transplantation UnitRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
TCD arm
Arm Description
All patients will be evaluated with TCD for prediction of the post-transplant neurological complications
Outcomes
Primary Outcome Measures
Post-transplant Neurological Complication
incidence of Neurological Complication as a composite outcome (tremors, seizures, demyelination, posterior reversible encephalopathy syndrome, stroke)
Secondary Outcome Measures
flow patterns throughout the transplant surgery and in the ICU
normal, hyperemic, low-flow, or vasospastic flow by TCD
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05144451
Brief Title
Transcranial Doppler During Liver Transplantation
Official Title
Transcranial Doppler and Neurological Complications After Liver Transplantation
Study Type
Interventional
2. Study Status
Record Verification Date
April 2022
Overall Recruitment Status
Recruiting
Study Start Date
November 28, 2021 (Actual)
Primary Completion Date
November 28, 2023 (Anticipated)
Study Completion Date
April 28, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Mansoura University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a prospective study that would investigate the transcranial doppler (TCD) changes during the living donor liver transplantation and the association between the TCD changes and the post-transplant neurological complications.
Detailed Description
Objectives:
Participants & Setting:
Intervention & Measurements:
Sample size:
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Liver Transplantation, Ultrasonography, Doppler, Transcranial, Complication, Postoperative, Neurologic Deficits
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
A single-arm trial involving 100 patients undergoing living donor liver transplantation; all will be examined using transcranial doppler to find out its predictive value on post-transplant neurological deficits.
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
TCD arm
Arm Type
Experimental
Arm Description
All patients will be evaluated with TCD for prediction of the post-transplant neurological complications
Intervention Type
Diagnostic Test
Intervention Name(s)
Transcranial Doppler
Other Intervention Name(s)
TCD
Intervention Description
Transcranial Doppler-derived parameters; pulsatility index (PI), resistance index (RI), mean flow velocity (Vmean) will be recorded before induction of anesthesia (T1).
After induction, TCD parameters, Hemodynamic variables including heart rate (HR), invasive mean arterial blood pressure (MAP), and central venous pressure (CVP) together with Arterial blood gases (ABG analysis with values of PH, PCO2, PO2, blood oxygen saturation SO2 and bicarbonate HCO3), end-tidal carbon dioxide (ETCO2) and body temperature will be recorded too. Just before skin incision (T2), at the end of anhepatic phase 5 minutes before reperfusion (T3), 5 minutes after reperfusion (T4) and at the end of surgery (T5).
Postoperatively at ICU, TCD parameters, Hemodynamic variables, and ABG will be obtained 24 hours postoperative (T6) and at discharge from ICU (T7).
Primary Outcome Measure Information:
Title
Post-transplant Neurological Complication
Description
incidence of Neurological Complication as a composite outcome (tremors, seizures, demyelination, posterior reversible encephalopathy syndrome, stroke)
Time Frame
28 days after transplantation
Secondary Outcome Measure Information:
Title
flow patterns throughout the transplant surgery and in the ICU
Description
normal, hyperemic, low-flow, or vasospastic flow by TCD
Time Frame
intraoperative and 7 days after transplantion
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
all patients scheduled for living donor liver transplantation for whatever the indication at Gastrointestinal surgery center (GISC)
Exclusion Criteria:
Patients with coexisting neuropsychiatric or cerebrovascular disorders or those who have a history of head trauma or brain surgery
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Moataz M Emara, MD, EDAIC
Phone
+201064048848
Email
mm.emara@mans.edu.eg
First Name & Middle Initial & Last Name or Official Title & Degree
Kareem M Abozeid, MSc
Phone
1557442411
Ext
+20
Email
kareemmohabozeid27@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Amr M Yassen, MD
Organizational Affiliation
Mansoura University Faculty of Medicine
Official's Role
Study Director
Facility Information:
Facility Name
Mansoura University, Gastrointestinal Surgery Center, Liver Transplantation Unit
City
Mansoura
State/Province
Dakahlia
ZIP/Postal Code
35516
Country
Egypt
Individual Site Status
Recruiting
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Data will be available with the corresponding author at reasonable request. The Data publishing with the manuscript will be discussed later.
IPD Sharing Time Frame
will be updated
IPD Sharing Access Criteria
will be updated
Learn more about this trial
Transcranial Doppler During Liver Transplantation
We'll reach out to this number within 24 hrs